Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON44655
NL-OMON44655
Completed
Not Applicable

MRI for radiotherapy treatment planning of stage III NSCLC: an MRI optimization study in healthy volunteers and patients - MRI optimization study in stage III NSCLC

niversitair Medisch Centrum Utrecht0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionslung cancernon-small cell lung cancer1003866610029107

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
lung cancer
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
40
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • •Healthy volunteers
  • •\- \*18 years
  • •\- written informed consent;Patients:
  • •\- patients with histopathologically or cytologically proven stage III NSCLC (excluding T4N0\) referred to the department of Radiation Oncology
  • •\- \* 18 years
  • •\- written informed consent
  • •\- recent (\* 3 months) GFR value available

Exclusion Criteria

  • •Healthy volunteers:
  • •\- volunteers who meet exclusion criteria for MRI following the protocol of the department of Radiology of the UMC Utrecht;Patients:
  • •\- patients who meet exclusion criteria for MRI following the protocol of the department of Radiology of the UMC Utrecht
  • •\- patients for whom lying still in a supine position for 45 minutes is physically too strenuous (e.g. due to orthopnea)
  • •\- Glomerular Filtration Rate (GFR) of \<30 mL/min/1\.73m2 (UMCU protocol \*MRI Contra\-indicaties\*, Version 3 January 2013\)
  • •\- patients with nephrogenic systemic fibrosis, nephrogenic fibrosing dermopathy or severe renal insufficiency (UMCU protocol \*MRI Contra\-indicaties\*, Version 3 January 2013\)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Ontwikkeling van een MRI-scanningsprotocol voor het afbeelden van stadium III niet-kleincellig longkanker.1. Healthy volunteers 2. Patients with stage III NSCLC MRI
NL-OMON27984niversity Medical Center Utrecht30
Completed
Not Applicable
Developing methods to allow adaptive radiotherapy for gynaecological cancers with Magnetic Resonance Imaging (MRI)Gynaecological CancerCancer - Cervical (cervix)Cancer - Womb (Uterine or endometrial cancer)Cancer - Other cancer types
ACTRN12615000862549Dr Karen Lim32
Withdrawn
Phase 2
MRI-guided single dose preoperative radiotherapy in low-risk breast cancerBreast cancermammary neoplasm10006291
NL-OMON46628niversitair Medisch Centrum Utrecht70
Unknown
Not Applicable
MRI Optimization Study in Stage III NSCLCStage III Non-small Cell Lung Cancer
NCT02076282UMC Utrecht30
Completed
Phase 2
Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Studyon-small cell lung cancer
JPRN-UMIN000017780Shizuoka Cancer Center22